STEPHEN A SHERWIN Insider Trading $NBIX NEUROCRINE BIOSCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for STEPHEN A SHERWIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of STEPHEN A SHERWIN. STEPHEN A SHERWIN is Chairman & C.E.O. in CELL GENESYS INC ($CEGE) and Chairman & Chief Exec. Officer in CELL GENESYS INC ($CEGE) and Chairman and CEO in CELL GENESYS INC ($CEGE) and Director in VICAL INC ($VICL) and Director in BIOGEN INC. ($IDPH) and Director in NEUROCRINE BIOSCIENCES INC ($NBIX) and Director in RIGEL PHARMACEUTICALS INC ($RIGL) and Director in ADURO BIOTECH, INC. ($ADRO) and Director in Verastem, Inc. ($VSTM) and Director in Neon Therapeutics, Inc. ($NTGN).
STEPHEN A SHERWIN in NEUROCRINE BIOSCIENCES INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of STEPHEN A SHERWIN: Director
Holdings: 29,861 shares
Current Value: $1,301,940
Latest Transaction: May 21 2020
$NBIX Market Capitalization: $3.81B
$NBIX Previous Close: $43.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of STEPHEN A SHERWIN in NEUROCRINE BIOSCIENCES INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IDPH, VICL, CEGE, ADRO, NTGN, NBIX, RIGL, VSTM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 21 2020 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 119.93 | 6,018 | 721,739 | 6,018 | |
| Apr 30 2020 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Sell | S | 99.39 | 17,687 | 1,757,966 | 29,861 | 47.5 K to 29.9 K (-37.20 %) |
| May 23 2019 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 79.79 | 10,000 | 797,900 | 10,000 | |
| Jun 13 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Sell | S | 98.44 | 10,000 | 984,420 | 47,548 | 57.5 K to 47.5 K (-17.38 %) |
| May 25 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 94.64 | 12,500 | 1,183,000 | 12,500 | |
| May 25 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 94.64 | 12,500 | 1,183,000 | 12,500 | |
| Apr 30 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 7.05 | 15,000 | 105,750 | 0 | |
| Apr 30 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 79.44 | 1,331 | 105,735 | 57,548 | 58.9 K to 57.5 K (-2.26 %) |
| Apr 30 2018 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 7.05 | 15,000 | 105,750 | 58,879 | 43.9 K to 58.9 K (+34.18 %) |
| Jun 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 53.64 | 15,000 | 804,600 | 15,000 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 3.40 | 15,000 | 51,000 | 0 | |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 43.60 | 1,169 | 50,968 | 43,879 | 45 K to 43.9 K (-2.60 %) |
| Feb 08 2017 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 3.40 | 15,000 | 51,000 | 45,048 | 30 K to 45 K (+49.92 %) |
| May 24 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 47.89 | 15,000 | 718,350 | 15,000 | |
| Apr 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 3.07 | 15,000 | 46,050 | 0 | |
| Apr 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 46.86 | 982 | 46,017 | 30,048 | 31 K to 30 K (-3.16 %) |
| Apr 18 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 3.07 | 15,000 | 46,050 | 31,030 | 16 K to 31 K (+93.57 %) |
| Jan 12 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | M | 4.76 | 15,000 | 71,400 | 0 | |
| Jan 12 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Payment of Exercise | F | 40.20 | 1,776 | 71,395 | 16,030 | 17.8 K to 16 K (-9.97 %) |
| Jan 12 2016 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Buy | M | 4.76 | 15,000 | 71,400 | 17,806 | 2.8 K to 17.8 K (+534.57 %) |
| Jun 01 2015 | NBIX | NEUROCRINE BIOSCIE ... | SHERWIN STEPHEN A | Director | Option Exercise | A | 42.76 | 25,000 | 1,069,000 | 25,000 |
Page: 1